Mereo BioPharma Group PLC (MREO)
3.26
+0.15
(+4.82%)
USD |
NASDAQ |
May 03, 16:00
3.265
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Total Assets (Quarterly): 66.50M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 66.50M |
| June 30, 2023 | 101.71M |
| June 30, 2023 | 101.71M |
| December 31, 2022 | 77.41M |
| June 30, 2022 | 131.04M |
| June 30, 2022 | 131.04M |
| December 31, 2021 | 170.62M |
| June 30, 2021 | 200.57M |
| June 30, 2021 | 200.57M |
| December 31, 2020 | 85.79M |
| June 30, 2020 | 135.13M |
| June 30, 2020 | 135.13M |
| December 31, 2019 | 113.35M |
| Date | Value |
|---|---|
| June 30, 2019 | 135.78M |
| June 30, 2019 | 135.78M |
| December 31, 2018 | 85.37M |
| June 30, 2018 | 107.31M |
| June 30, 2018 | 107.31M |
| December 31, 2017 | 130.19M |
| June 30, 2017 | 116.73M |
| June 30, 2017 | 116.73M |
| December 31, 2016 | 107.05M |
| June 30, 2016 | 134.49M |
| June 30, 2016 | 134.49M |
| December 31, 2015 | 59.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
66.50M
Minimum
Dec 2023
200.57M
Maximum
Jun 2021
128.14M
Average
131.04M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 13.43M |
| NuCana PLC | 35.43M |
| TC BioPharm (Holdings) PLC | 11.38M |
| Adaptimmune Therapeutics PLC | 282.62M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.96M |
| Shareholders Equity (Quarterly) | 50.54M |
| Debt to Equity Ratio | 0.0869 |
| Current Ratio | 6.722 |
| Net Debt Paydown Yield | 1.54% |